Blood MicroRNA Signatures Serve As Potential Diagnostic Biomarkers for Hepatic Sinusoidal Obstruction Syndrome Caused by Containing Pyrrolizidine Alkaloids

Overview

Journal Front Pharmacol

Date 2021 Mar 8

PMID 33679405

Citations 3

Authors

Xunjiang Wang

Wei Zhang

Yongfeng Yang

Yiran Chen

Yuzheng Zhuge

Aizhen Xiong

Li Yang

Zhengtao Wang

Affiliations

Soon will be listed here.

Abstract

The -induced hepatic sinusoidal obstruction syndrome (HSOS) is closely related to pyrrolizidine alkaloids (PAs), and its prevalence has been increasing worldwide in recent years. However, no effective therapy for PA-induced HSOS in clinics is available, partially due to the failure of quick diagnosis. This study aims to identify blood microRNA (miRNA) signatures as potential biomarkers for PA-induced HSOS in clinics. The microarray-based miRNA profiling was performed on blood samples of the discovery cohort, which consisted of nine patients with HSOS and nine healthy donors. Differentially expressed miRNAs were further confirmed using a validation cohort, which consisted of 20 independent patients with HSOS. In addition, the rat model was established through the oral administration of the total alkaloid extract from to investigate the association of miRNA biomarkers with the progression of HSOS. Bioinformatic analyses, including GO and KEGG enrichment, receiver operating characteristics curve, and correlation analyses were conducted to evaluate the accuracy of the potential miRNA biomarkers. Three miRNAs, namely miR-148a-3p, miR-362-5p, and miR-194-5p, were overexpressed in patients and rats with PA-induced HSOS. These miRNAs were positively related to the severity of liver injury and displayed considerable diagnostic accuracy for patients with HSOS with areas under the curve over 0.87. In summary, this study demonstrated that three miRNAs, hsa-miR-148a-3p, hsa-miR-362-5p, and hsa-miR-194-5p, might serve as potential biomarkers for PA-induced HSOS in clinics.

Citing Articles

Drug-induced hepatic sinusoidal obstruction syndrome: current advances and future perspectives.

Yu Z, Li W, Tian C, Cao Y, Zhang C Arch Toxicol. 2024; 99(3):835-850.

PMID: 39718593 DOI: 10.1007/s00204-024-03950-9.

Identification of microRNAs Implicated in Modulating Senecionine-Induced Liver Toxicity in HepaRG Cells.

Enge A, Sprenger H, Braeuning A, Hessel-Pras S Foods. 2022; 11(4).

PMID: 35206009 PMC: 8871147. DOI: 10.3390/foods11040532.

Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update.

Teschke R, Vongdala N, Quan N, Quy T, Xuan T Int J Mol Sci. 2021; 22(19).

PMID: 34638760 PMC: 8508847. DOI: 10.3390/ijms221910419.

References

Busk P . A tool for design of primers for microRNA-specific quantitative RT-qPCR. BMC Bioinformatics. 2014; 15:29. PMC: 3922658. DOI: 10.1186/1471-2105-15-29. View

Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M . Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem. 2000; 49(1):121-30. DOI: 10.1177/002215540104900112. View

Danese S, Papa A, Saibeni S, Repici A, Malesci A, Vecchi M . Inflammation and coagulation in inflammatory bowel disease: The clot thickens. Am J Gastroenterol. 2006; 102(1):174-86. DOI: 10.1111/j.1572-0241.2006.00943.x. View

Van der Ree M, Jansen L, Kruize Z, van Nuenen A, van Dort K, Takkenberg R . Plasma MicroRNA Levels Are Associated With Hepatitis B e Antigen Status and Treatment Response in Chronic Hepatitis B Patients. J Infect Dis. 2017; 215(9):1421-1429. DOI: 10.1093/infdis/jix140. View

Zhuge Y, Liu Y, Xie W, Zou X, Xu J, Wang J . Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. J Gastroenterol Hepatol. 2019; 34(4):634-642. DOI: 10.1111/jgh.14612. View

Oda S, Takeuchi M, Akai S, Shirai Y, Tsuneyama K, Yokoi T . miRNA in Rat Liver Sinusoidal Endothelial Cells and Hepatocytes and Application to Circulating Biomarkers that Discern Pathogenesis of Liver Injuries. Am J Pathol. 2018; 188(4):916-928. DOI: 10.1016/j.ajpath.2017.12.007. View

Jefferson B, Ali M, Grant S, Frampton G, Ploof M, Andry S . Thrombospondin-1 Exacerbates Acute Liver Failure and Hepatic Encephalopathy Pathology in Mice by Activating Transforming Growth Factor β1. Am J Pathol. 2019; 190(2):347-357. PMC: 7013272. DOI: 10.1016/j.ajpath.2019.10.003. View

Huang Z, Chen M, Zhang J, Sheng Y, Ji L . Integrative analysis of hepatic microRNA and mRNA to identify potential biological pathways associated with monocrotaline-induced liver injury in mice. Toxicol Appl Pharmacol. 2017; 333:35-42. DOI: 10.1016/j.taap.2017.08.007. View

Bates S . D-dimer assays in diagnosis and management of thrombotic and bleeding disorders. Semin Thromb Hemost. 2012; 38(7):673-82. DOI: 10.1055/s-0032-1326782. View

10.

Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M . Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology. 2019; 156(8):2230-2241.e11. DOI: 10.1053/j.gastro.2019.02.002. View

11.

Bockhorn M, Goralski M, Prokofiev D, Dammann P, Grunewald P, Trippler M . VEGF is important for early liver regeneration after partial hepatectomy. J Surg Res. 2007; 138(2):291-9. DOI: 10.1016/j.jss.2006.07.027. View

12.

Sternlicht M, Werb Z . How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001; 17:463-516. PMC: 2792593. DOI: 10.1146/annurev.cellbio.17.1.463. View

13.

Zhang F, Zhou Y, Yang X, Xiong A, Wang Z, Yang L . Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors. Acta Pharmacol Sin. 2018; 40(6):781-789. PMC: 6786394. DOI: 10.1038/s41401-018-0155-y. View

14.

Ameres S, Zamore P . Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol. 2013; 14(8):475-88. DOI: 10.1038/nrm3611. View

15.

Saray A, Mesihovic R, Gornjakovic S, Vanis N, Mehmedovic A, Nahodovic K . Association between high D-dimer plasma levels and ascites in patients with liver cirrhosis. Med Arch. 2013; 66(6):372-4. DOI: 10.5455/medarh.2012.66.372-374. View

16.

Vliegenthart A, Berends C, Potter C, Kersaudy-Kerhoas M, Dear J . MicroRNA-122 can be measured in capillary blood which facilitates point-of-care testing for drug-induced liver injury. Br J Clin Pharmacol. 2017; 83(9):2027-2033. PMC: 5555871. DOI: 10.1111/bcp.13282. View

17.

Chen Y, Duan J . Diagnostic Value of Peripheral Blood miR-148a-3p in Patients with Liver Injury After Hepatectomy Under General Anesthesia with Propofol. Clin Lab. 2020; 66(3). DOI: 10.7754/Clin.Lab.2019.190814. View

18.

Howell L, Ireland L, Park B, Goldring C . MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury. Expert Rev Mol Diagn. 2017; 18(1):47-54. DOI: 10.1080/14737159.2018.1415145. View

19.

Guo T, Li X, Yang X, Kong X, Liu H, Bai T . Gadoxetic Acid-Enhanced Hepatobiliary-Phase Magnetic Resonance Imaging for Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome and Association with Liver Function. Sci Rep. 2019; 9(1):1231. PMC: 6362127. DOI: 10.1038/s41598-018-37775-1. View

20.

Davis G, Pintar Allen K, Salazar R, Maxwell S . Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J Cell Sci. 2001; 114(Pt 5):917-30. DOI: 10.1242/jcs.114.5.917. View